Erratum: The puzzle of TRPV4 channelopathies (EMBO Reports (2013) 14 (152-163) DOI:10.1038/embor.2012.219);The puzzle of TRPV4 channelopathies

EMBO Reports

Volumn 14, Issue 2, 2013, Pages 152-163

  Nilius, Bernd ^a   Voets, Thomas ^a  

^a LABORATORY OF MOLECULAR AND CELLULAR SIGNALING   (Belgium)

Author keywords

cation channels; neuropathy; skeletal disease; transient receptor potential

Indexed keywords

TRANSIENT RECEPTOR POTENTIAL CHANNEL 4;

BONE DISEASE; BONE DYSPLASIA; CHANNELOPATHY; GENE MUTATION; HEREDITARY SPINAL MUSCULAR ATROPHY; NEUROPATHY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SYMPTOMATOLOGY;

EID: 84873413090     PISSN: 1469221X     EISSN: 14693178     Source Type: Journal    
DOI: 10.1038/embor.2013.134     Document Type: Erratum

References (99)

1. Everaerts W, Nilius B, Owsianik G (2010) The vallinoid transient receptor potential channel Trpv4: from structure to disease. Prog Biophys Mol Biol 103: 2-17
2. Liedtke W, Choe Y, Marti-Renom MA, Bell AM, Denis CS, Sali A, Hudspeth AJ, Friedman JM, Heller S (2000) Vanilloid receptor-related osmotically activated channel (VR-OAC), a candidate vertebrate osmoreceptor. Cell 103: 525-535
3. Strotmann R, Harteneck C, Nunnenmacher K, Schultz G, Plant TD (2000) OTRPC4, a nonselective cation channel that confers sensitivity to extracellular osmolarity. Nat Cell Biol 2: 695-702
4. Vriens J, Watanabe H, Janssens A, Droogmans G, Voets T, Nilius B (2004) Cell swelling, heat, and chemical agonists use distinct pathways for the activation of the cation channel TRPV4. Proc Natl Acad Sci USA 101: 396-401
5. Vriens J et al (2005) Modulation of the Ca2 permeable cation channe TRPV4 by cytochrome P450 epoxygenases in vascular endothelium. Circ Res 97: 908-915
6. Watanabe H, Vriens J, Suh SH, Benham CD, Droogmans G, Nilius B (2002) Heat-evoked activation of TRPV4 channels in a HEK293 cel expression system and in native mouse aorta endothelial cells. J Biol Chem 277: 47044-47051
7. Watanabe H et al (2002) Activation of TRPV4 channels (h VRL-2/m TRP12) by phorbol derivatives. J Biol Chem 277: 13569-13577
8. Watanabe H, Vriens J, Janssens A, Wondergem R, Droogmans G, Nilius B (2003) Modulation of TRPV4 gating by intra-and extracellular Ca2+. Cell Calcium 33: 489-495
9. Watanabe H, Vriens J, Prenen J, Droogmans G, Voets T, Nilius B (2003) Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels. Nature 424: 434-438
10. Thorneloe KS et al (2008) N-((1S)-1-{[4-((2S)-2-{[(2,4-dichlorophenyl) sulfonyl]amino}-3-hydroxypropanoyl)-1-piperazinyl]carbonyl}-3-methylbutyl) -1-benzothiophene-2-carboxamide (GSK1016790A), a novel and potent TRPV4 channel agonist induces urinary bladder contraction and hyperactivity: Part I. J Pharmacol Exp Ther 326: 432-442
11. Klausen TK et al (2009) Modulation of the transient receptor potential vanilloid channel TRPV4 by 4alpha-phorbol esters: a structure-activity study. J Med Chem 52: 2933-2939
12. Vincent F et al (2009) Identification and characterization of nove TRPV4 modulators. Biochem Biophys Res Commun 389: 490-494
13. Vriens J, Owsianik G, Janssens A, Voets T, Nilius B (2007) Determinants of 4alpha-phorbol sensitivity in transmembrane domains 3 and 4 of the cation channel TRPV4. J Biol Chem 282: 12796-12803
14. Suzuki M, Mizuno A, Kodaira K, Imai M (2003) Impaired pressure sensation with mice lacking TRPV4. J Biol Chem 278: 22664-22668
15. Ma X, He D, Ru X, Chen Y, Cai Y, Bruce IC, Xia Q, Yao X, Jin J (2011) Apigenin, a plant-derived flavone, activates transient receptor potential TRPV4 cation channel. Br J Pharmacol 166: 349-358
16. Voets T, Prenen J, Vriens J, Watanabe H, Janssens A, Wissenbach U, Bödding M, Droogmans G, Nilius B (2002) Molecular determinants of permeation through the cation channel TRPV4. J Biol Chem 277: 33704-33710
17. Everaerts W et al (2010) Inhibition of the cation channel TRPV4 improves bladder function in mice and rats with cyclophosphamide-induced cystitis. Proc Natl Acad Sci USA 107: 19084-19089
18. Nilius B, Owsianik G (2011) The transient receptor potential family of ion channels. Genome Biol 12: 218-229
19. Owsianik G, D'hoedt D, Voets T, Nilius B (2006) Structure-function relationship of the TRP channel superfamily. Rev Physiol Biochem Pharmacol 156: 61-90
20. Phelps CB, Huang RJ, Lishko PV, Wang RR, Gaudet R (2008) Structural analyses of the ankyrin repeat domain of TRPV6 and related TRPV ion channels. Biochemistry 47: 2476-2484
21. Inada H, Procko E, Sotomayor M, Gaudet R (2012) Structural and biochemical consequences of disease-causing mutations in the ankyrin repeat domain of the human TRPV4 channel. Biochemistry 51: 6195-6206
22. Cuajungco MP, Grimm C, Oshima K, D'Hoedt D, Nilius B, Mensenkamp AR, Bindels RJ, Plomann M, Heller S (2006) PACSINs bind to the TRPV4 cation channel: PACSIN 3 modulates the subcellular localization of TRPV4. J Biol Chem 281: 18753-18762
23. D'hoedt, D, Owsianik G, Prenen P, Cuajungco MP, Grimm G, Heller S, Voets T, Nilius B (2007) Stimulus-specific modulation of the cation channel TRPV4 by PACSIN 3. J Biol Chem 283: 6272-6280
24. Wang Y, Fu X, Gaiser S, Kottgen M, Kramer-Zucker A, Walz G, Wegierski T (2007) OS-9 regulates the transit and polyubiquitination of TRPV4 in the endoplasmic reticulum. J Biol Chem 282: 36561-36570
25. Strotmann R, Schultz G, Plant TD (2003) Ca2+-dependent potentiation of the nonselective cation channel TRPV4 is mediated by a C-terminal calmodulin binding site. J Biol Chem 278: 26541-26549
26. Suzuki M, Hirao A, Mizuno A (2003) Microtubule-associated protein 7 increases the membrane expression of transient receptor potential vanilloid 4 (TRPV4). J Biol Chem 278: 51448-51453
27. Goswami C, Kuhn J, Heppenstall PA, Hucho T (2010) Importance of non-selective cation channel TRPV4 interaction with cytoskeleton and their reciprocal regulations in cultured cells. PLo S ONE 5: e11654
28. Garcia-Elias A, Lorenzo IM, Vicente R, Valverde MA (2008) IP3 receptor binds to and sensitizes TRPV4 channel to osmotic stimuli via a calmodulin-binding site. J Biol Chem 283: 31284-31288
29. Eid SR (2011) Therapeutic targeting of TRP channels\the TR(i)P to pain relief. Curr Top Med Chem 11: 2118-2130
30. Shen J, Harada N, Kubo N, Liu B, Mizuno A, Suzuki M, Yamashita T (2006) Functional expression of transient receptor potential vanilloid 4 in the mouse cochlea. Neuroreport 17: 135-139
31. Adapala RK, Thoppil R, Luther DJ, Paruchuri S, Meszaros JG, Chilian WM, Thodeti CK (2013) TRPV4 channels mediate cardiac fibroblast differentiation by integrating mechanical and soluble signals. J Mol Cell Cardiol 54: 45-52
32. Ho TC, Horn NA, Huynh T, Kelava L, Lansman JB (2012) Evidence TRPV4 contributes to mechanosensitive ion channels in mouse skeletal muscle fibers. Channels (Austin) 6: 246-254
33. Kida N et al (2012) Importance of transient receptor potential vanilloid 4 (TRPV4) in epidermal barrier function in human skin keratinocytes. Pflugers Arch 463: 715-725
34. Ye L et al (2012) TRPV4 is a regulator of adipose oxidative metabolism, inflammation, and energy homeostasis. Cell 151: 96-110
35. Muramatsu S et al (2007) Functional gene screening system identified TRPV4 as a regulator of chondrogenic differentiation. J Biol Chem 282: 32158-32167
36. Lewis R, Asplin KE, Bruce G, Dart C, Mobasheri A, Barrett-Jolley R (2011) The role of the membrane potential in chondrocyte volume regulation. J Cell Physiol 226: 2979-2986
37. Gevaert T et al (2007) Deletion of the transient receptor potential cation channel TRPV4 impairs murine bladder voiding. J Clin Invest 117: 3453-3462
38. Masuyama R et al (2008) TRPV4-mediated calcium influx regulates terminal differentiation of osteoclasts. Cell Metab 8: 257-265
39. -/-mice. Proc Natl Acad Sci USA 100: 13698-13703
40. Liedtke W (2008) Molecular mechanisms of TRPV4-mediated neural signaling. Ann NY Acad Sci 1144: 42-52
41. Earley S, Heppner TJ, Nelson MT, Brayden JE (2005) TRPV4 forms a novel Ca2+ signaling complex with ryanodine receptors and BKCa channels. Circ Res 97: 1270-1279
42. Marrelli SP, O'Neil R, G, Brown RC, Bryan RM (2006) PLA2 and TRPV4 channels regulate endothelial calcium in cerebral arteries. Am J Physiol Heart Circ Physiol 292: H1390-H1397
43. Saliez J et al (2008) Role of caveolar compartmentation in endothelium-derived hyperpolarizing factor-mediated relaxation: Ca2+ signals and gap junction function are regulated by caveolin in endothelial cells. Circulation 117: 1065-1074
44. Loot AE, Popp R, Fisslthaler B, Vriens J, Nilius B, Fleming I (2008) Role of cytochrome P450-dependent TRPV4 activation in flow-induced vasodilatation. Cardiovasc Res 80: 445-452
45. Sonkusare SK, Bonev AD, Ledoux L, Liedtke W, Kotlikoff MI, Heppner TJ, Hill-Eubanks DC, Nelson MT (2012) Elementary Ca2+ signals through endothelial TRPV4 channels regulate vascular function. Science 336: 597-601
46. Tabuchi K, Suzuki M, Mizuno A, Hara A (2005) Hearing impairment in TRPV4 knockout mice. Neurosci Lett 382: 304-308
47. Cortright DN, Szallasi A (2009) TRP channels and pain. Curr Pharm Des 15: 1736-1749
48. Thorneloe KS et al (2012) An orally active TRPV4 channel blocker prevents and resolves pulmonary edema induced by heart failure. Sci Transl Med 4: 159ra148
49. Nilius B, Owsianik G (2010) Channelopathies converge on TRPV4. Nat Genet 42: 98-100
50. Morquio L (1929) Sur une forme de dystrophie osseuse familiale. Archives de Médecine des Infants 32: 129-135
51. Nishimura G et al (2010) Spondylo-epiphyseal dysplasia, Maroteaux type (pseudo-Morquio syndrome type 2), and parastremmatic dysplasia are caused by TRPV4 mutations. Am J Med Genet A 152A: 1443-1449
52. Rock MJ et al (2008) Gain-of-function mutations in TRPV4 cause autosomal dominant brachyolmia. Nat Genet 40: 999-1003
53. Krakow D et al (2009) Mutations in the gene encoding the calcium-permeable ion channel TRPV4 produce spondylometaphyseal dysplasia, Kozlowski type and metatropic dysplasia. Am J Hum Genet 84: 307-315
54. Unger S et al (2011) Fetal akinesia in metatropic dysplasia: The combined phenotype of chondrodysplasia and neuropathy? Am J Med Genet A 155A: 2860-2864
55. Camacho N, Krakow D, Johnykutty S, Katzman PJ, Pepkowitz S, Vriens J, Nilius B, Boyce BF, Cohn DH (2010) Dominant TRPV4 mutations in nonlethal and lethal metatropic dysplasia. Am J Med Genet A 152A: 1169-1177
56. Nishimura G, Lausch E, Savarirayan R, Shiba M, Spranger J, Zabel B, kegawa S, Superti-Furga A, Unger S (2012) TRPV4-associated skeletal dysplasias. Am J Med Genet C Semin Med Genet 160C: 190-204
57. Mc Entagart M (2012) TRPV4 axonal neuropathy spectrum disorder. J Clin Neurosci 19: 927-933
58. Dubowitz V (1995) Disorders of the Lower Motor Neurone: The Spinal Muscular Atrophies. London, UK: Saunders
59. Main M, Kairon H, Mercuri E, Muntoni F (2003) The Hammersmith functional motor scale for children with spinal muscular atrophy: a scale to test ability and monitor progress in children with limited ambulation. Eur J Paediatr Neurol 7: 155-159
60. Rossor AM, Kalmar B, Greensmith L, Reilly MM (2011) The distal hereditary motor neuropathies. J Neurol Neurosurg Psychiatry 83: 6-14
61. Drew AP, Blair IP, Nicholson GA (2011) Molecular genetics and mechanisms of disease in distal hereditary motor neuropathies: insights directing future genetic studies. Curr Mol Med 11: 650-665
62. Vlam L, Schelhaas HJ, van Blitterswijk M, van Vught PW, de Visser M, van der Kooi AJ, van der Pol WL, van den Berg LH (2012) Mutations in the TRPV4 gene are not associated with sporadic progressive muscular atrophy. Arch Neurol 69: 790-791
63. Fiorillo C et al (2012) TRPV4 mutations in children with congenital distal spinal muscular atrophy. Neurogenetics 13: 195-203
64. De Long R, Siddique T (1992) A large New England kindred with autosomal dominant neurogenic scapuloperoneal amyotrophy with unique features. Arch Neurol 49: 905-908
65. Deng HX et al (2010) Scapuloperoneal spinal muscular atrophy and hereditary motor and sensory neuropathy type IIC are allelic disorders caused by mutations in TRPV4. Nat Genet 42: 165-169
66. Siskind CE, Shy ME (2011) Genetics of neuropathies. Semin Neurol 31: 494-505
67. Berciano J (2011) Peripheral neuropathies: molecular diagnosis of Charcot-Marie-Tooth disease. Nat Rev Neurol 7: 305-306
68. Chen DH, Sul Y, Weiss M, Hillel A, Lipe H, Wolff J, Matsushita M, Raskind W, Bird T (2010) CMT2C with vocal cord paresis associated with short stature and mutations in the TRPV4 gene. Neurology 75: 1968-1975
69. Zimon M et al (2010) Dominant mutations in the cation channel gene transient receptor potential vanilloid 4 cause an unusual spectrum of neuropathies. Brain 33: 1798-1809
70. Auer-Grumbach M et al (2010) Alterations in the N-terminal ankyrin domain of TRPV4 cause congenital and scapuloperoneal spinal muscular atrophy, and hereditary motor and sensory neuropathy 2C. Nat Genet 42: 160-164
71. Landouré G et al (2010) Mutations in TRPV4 cause Charcot-Marie-Tooth disease type 2C. Nat Genet 42: 170-174
72. Fawcett KA et al (2012) Comprehensive analysis of the TRPV4 gene in a arge series of inherited neuropathies and controls. J Neurol Neurosurg Psychiatry 83: 1204-1209
73. Lamande SR et al (2011) Mutations in TRPV4 cause an inherited arthropathy of hands and feet. Nat Genet 43: 1142-1146
74. Baets J, De Jonghe P (2011) TRPV4 neuropathies: Calcium channe inhibition as a therapeutic target? Neurology 76: 856-857
75. Loukin S, Zhou X, Su Z, Saimi Y, Kung C (2010) Wild-type and brachyolmia-causing mutant TRPV4 channels respond directly to stretch force. J Biol Chem 285: 27176-27181
76. Klein CJ et al (2011) TRPV4 mutations and cytotoxic hypercalcemia in axonal Charcot-Marie-Tooth neuropathies. Neurology 76: 887-894
77. Janssens A, Voets T (2011) Ligand stoichiometry of the cold-and menthol-activated channel TRPM8. J Physiol 589: 4827-4835
78. Arniges M, Fernandez-Fernandez JM, Albrecht N, Schaefer M, Valverde MA (2006) Human TRPV4 channel splice variants revealed a key role of ankyrin domains in multimerization and trafficking. J Biol Chem 281: 1580-1586
79. Masuyama R, Mizuno A, Komori H, Kajiya H, Uekawa A, Kitaura H, Okabe K, Ohyama K, Komori T (2012) Calcium/calmodulin-signaling supports TRPV4 activation in osteoclasts and regulates bone mass. J Bone Miner Res 27: 1708-1721
80. Klasen K, Hollatz D, Zielke S, Gisselmann G, Hatt H, Wetzel CH (2012) The TRPM8 ion channel comprises direct Gq protein-activating capacity. Pflugers Archiv 463: 779-797
81. Desai BN et al (2012) Cleavage of TRPM7 releases the kinase domain from the ion channel and regulates its participation in Fas-induced apoptosis. Dev Cell 22: 1149-1162
82. Fecto F, Shi Y, Huda R, Martina M, Siddique T, Deng HX (2011) Mutant TRPV4-mediated toxicity is linked to increased constitutive function in axonal neuropathies. J Biol Chem 286: 17281-17291
83. Jang Y et al (2012) Axonal neuropathy-associated TRPV4 regulates neurotrophic factor-derived axonal growth. J Biol Chem 287: 6014-6024
84. Kornak U, Mundlos S (2003) Genetic disorders of the skeleton: a developmental approach. Am J Hum Genet 73: 447-474
85. Guilak F, Leddy HA, Liedtke W (2010) Transient receptor potential vanilloid 4. Ann NY Acad Sci 1192: 404-409
86. Zerangue N, Schwappach B, Jan YN, Jan LY (1999) A new ER trafficking signal regulates the subunit stoichiometry of plasma membrane K(ATP) channels. Neuron 22: 537-548
87. Owsianik G, Cao L, Nilius B (2003) Rescue of functional Delta F508-CFTR channels by co-expression with truncated CFTR constructs in COS-1 cells. FEBS Lett 554: 173-178
88. Verma P, Kumar A, Goswami C (2010) TRPV4-mediated channelopathies. Channels (Austin) 4: 319-328
89. Wegierski T, Hill K, Schaefer M, Walz G (2006) The HECT ubiquitin ligase AIP4 regulates the cell surface expression of select TRP channels. EMBO J 25: 5659-5669
90. Lanciotti A et al (2012) Megalencephalic leukoencephalopathy with subcortical cysts protein 1 functionally cooperates with the TRPV4 cation channel to activate the response of astrocytes to osmotic stress: dysregulation by pathological mutations. Hum Mol Genet 21: 2166-2180
91. Li J et al (2011) TRPV4-mediated calcium influx into human bronchial epithelia upon exposure to diesel exhaust particles. Environ Health Perspect 119: 784-793
92. Tian W et al (2009) A loss-of-function nonsynonymous polymorphism in the osmoregulatory TRPV4 gene is associated with human hyponatremia. Proc Natl Acad Sci USA 106: 14034-14039
93. Dai J et al (2010) Novel and recurrent TRPV4 mutations and their association with distinct phenotypes within the TRPV4 dysplasia family J Med Genet 47: 704-709
94. Cho TJ et al (2012) TRPV4-pathy manifesting both skeletal dysplasia and peripheral neuropathy: A report of three patients. Am J Med Genet A 158A: 795-802
95. Astrea G, Brisca G, Fiorillo C, Valle M, Tosetti M, Bruno C, Santorelli FM, Battini R (2012) Muscle MRI in TRPV4-related congenital distal SMA. Neurology 78: 364-365
96. Landoure G et al (2012) Exome sequencing identifies a novel TRPV4 mutation in a CMT2C family. Neurology 79: 192-194
97. Aharoni S, Harlalka G, Offiah A, Shuper A, Crosby AH, Mc Entagart M (2011) Striking phenotypic variability in familial TRPV4-axonal neuropathy spectrum disorder. Am J Med Genet A 155A: 3153-3156
98. Andreucci E et al (2011) TRPV4 related skeletal dysplasias: a phenotypic spectrum highlighted byclinical, radiographic, and molecular studies in 21 new families. Orphanet J Rare Dis 6: 37
99. Kang SS, Shin SH, Auh CK, Chun JS (2012) Human skeletal dysplasia caused by a constitutive activated transient receptor potential vanilloid 4 (TRPV4) cation channel mutation. Exp Mol Med 44: 707-722